Transcriptomic heterogeneity of cultured ADSCs corresponds to embolic risk in the host

Transcriptomic heterogeneity of cultured ADSCs corresponds to embolic risk in the host

Summary: Stem cell therapy emerges as an effective approach for treating various currently untreatable diseases. However, fatal and unknown risks caused by their systemic use remain to be a major obstacle to clinical application. We developed a functional single-cell RNA sequencing (scRNA-seq) proce...

Full description

Bibliographic Details
Main Authors: Kaijing Yan, Jinlai Zhang, Wen Yin, Jeffrey N. Harding, Fei Ma, Di Wu, Haibo Deng, Pengfei Han, Rui Li, Hongxu Peng, Xin Song, Y. James Kang
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:iScience
Subjects:
Stem cells research
computational bioinformatics
transcriptomics
Online Access:http://www.sciencedirect.com/science/article/pii/S258900422201094X

Similar Items

Similar Items